| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |